Mark L. Bagarazzi

3.9k total citations · 1 hit paper
38 papers, 2.0k citations indexed

About

Mark L. Bagarazzi is a scholar working on Virology, Immunology and Epidemiology. According to data from OpenAlex, Mark L. Bagarazzi has authored 38 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Virology, 21 papers in Immunology and 15 papers in Epidemiology. Recurrent topics in Mark L. Bagarazzi's work include HIV Research and Treatment (21 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (8 papers). Mark L. Bagarazzi is often cited by papers focused on HIV Research and Treatment (21 papers), Immunotherapy and Immune Responses (15 papers) and Immune Cell Function and Interaction (8 papers). Mark L. Bagarazzi collaborates with scholars based in United States, Italy and Canada. Mark L. Bagarazzi's co-authors include David B. Weiner, Jean Boyer, Michael A. Chattergoon, Richard B. Ciccarelli, Kenneth E. Ugen, Richard S. Ginsberg, Rob Roy MacGregor, Velpandi Ayyavoo, Leslie R. Coney and Katie E. Lacy and has published in prestigious journals such as Journal of Clinical Oncology, Nature Biotechnology and The Journal of Immunology.

In The Last Decade

Mark L. Bagarazzi

37 papers receiving 1.9k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response

1998 503 citations Rob Roy MacGregor, Jean Boyer et al. The Journal of Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark L. Bagarazzi United States	20	1.3k	687	621	585	428	38	2.0k
Margherita Rosati United States	30	1.5k 1.1×	596 0.9×	937 1.5×	483 0.8×	555 1.3×	71	2.3k
Linda S. Klavinskis United Kingdom	27	1.5k 1.1×	499 0.7×	627 1.0×	580 1.0×	500 1.2×	56	2.4k
Frédéric Martinon France	21	986 0.7×	684 1.0×	379 0.6×	324 0.6×	449 1.0×	54	1.8k
James T. Fuller United States	17	893 0.7×	457 0.7×	472 0.8×	487 0.8×	446 1.0×	26	1.5k
Kesen Dang United States	22	1.6k 1.2×	807 1.2×	647 1.0×	570 1.0×	535 1.3×	27	2.4k
Lynda Tussey United States	23	1.7k 1.2×	773 1.1×	308 0.5×	1.1k 1.9×	458 1.1×	35	2.7k
Ludwig Deml Germany	23	765 0.6×	523 0.8×	488 0.8×	431 0.7×	268 0.6×	53	1.5k
Denise M. McKinney United States	25	1.1k 0.8×	899 1.3×	300 0.5×	687 1.2×	490 1.1×	32	2.2k
Jeffrey D. Ahlers United States	29	2.4k 1.8×	904 1.3×	1.3k 2.2×	887 1.5×	529 1.2×	44	3.4k
Isabelle Mondor France	18	1.2k 0.9×	602 0.9×	1.0k 1.7×	313 0.5×	455 1.1×	22	2.2k

Countries citing papers authored by Mark L. Bagarazzi

Since Specialization

Citations

This map shows the geographic impact of Mark L. Bagarazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark L. Bagarazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark L. Bagarazzi more than expected).

Fields of papers citing papers by Mark L. Bagarazzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark L. Bagarazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark L. Bagarazzi. The network helps show where Mark L. Bagarazzi may publish in the future.

Co-authorship network of co-authors of Mark L. Bagarazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mark L. Bagarazzi. A scholar is included among the top collaborators of Mark L. Bagarazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark L. Bagarazzi. Mark L. Bagarazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Morrow, Matthew P., Kimberly A. Kraynyak, Albert J. Sylvester, et al.. (2017). Clinical and Immunologic Biomarkers for Histologic Regression of High-Grade Cervical Dysplasia and Clearance of HPV16 and HPV18 after Immunotherapy. Clinical Cancer Research. 24(2). 276–294. 34 indexed citations

Shore, Neal D., Elisabeth I. Heath, Luke T. Nordquist, et al.. (2017). Safety and immunogenicity of a DNA-vaccine immunotherapy in men with biochemically (PSA) relapsed prostate cancer. Annals of Oncology. 28. v272–v272. 1 indexed citations

Yang, Z, Charu Aggarwal, Roger B. Cohen, et al.. (2015). Immunotherapy with INO-3112 (HPV16 and HPV18 plasmids + IL-12 DNA) in human papillomavirus (HPV) associated head and neck squamous cell carcinoma (HNSCCa). Annals of Oncology. 26. viii1–viii1. 2 indexed citations

Kraynyak, Kimberly A., Angela M. Bodles-Brakhop, & Mark L. Bagarazzi. (2015). Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy. Current topics in microbiology and immunology. 405. 55–78. 7 indexed citations

Morrow, Matthew P., Pablo Tebas, Jian Yan, et al.. (2014). Synthetic Consensus HIV-1 DNA Induces Potent Cellular Immune Responses and Synthesis of Granzyme B, Perforin in HIV Infected Individuals. Molecular Therapy. 23(3). 591–601. 14 indexed citations

Morrow, Matthew P., Kimberly A. Kraynyak, Xuefei Shen, et al.. (2014). Boosting of cellular and humoral immune responses to HPV16/18 antigens by VGX-3100: A follow-on phase I trial.. Journal of Clinical Oncology. 32(15_suppl). 3101–3101. 1 indexed citations

Diehl, Malissa, Jessica C. Lee, Stephen E. Daniels, et al.. (2013). Tolerability of intramuscular and intradermal delivery by CELLECTRA^®adaptive constant current electroporation device in healthy volunteers. Human Vaccines & Immunotherapeutics. 9(10). 2246–2252. 64 indexed citations

Bagarazzi, Mark L., Jian Yan, Matthew P. Morrow, et al.. (2012). Immunotherapy Against HPV16/18 Generates Potent T _H 1 and Cytotoxic Cellular Immune Responses. Science Translational Medicine. 4(155). 155ra138–155ra138. 229 indexed citations

Muthumani, Kar, Sagar B. Kudchodkar, Donghui Zhang, et al.. (2002). Issues for improving multiplasmid DNA vaccines for HIV-1. Vaccine. 20(15). 1999–2003. 29 indexed citations

10.

Boyer, Jean, Adam D. Cohen, Kenneth E. Ugen, et al.. (2000). Therapeutic immunization of HIV-infected chimpanzees using HIV-1 plasmid antigens and interleukin-12 expressing plasmids. AIDS. 14(11). 1515–1522. 55 indexed citations

11.

Boyer, Jean, Adam D. Cohen, K. E. Lacy, et al.. (2000). Vaccination of Seronegative Volunteers with a Human Immunodeficiency Virus Type 1env/revDNA Vaccine Induces Antigen‐Specific Proliferation and Lymphocyte Production of β‐Chemokines. The Journal of Infectious Diseases. 181(2). 476–483. 123 indexed citations

12.

Bagarazzi, Mark L., et al.. (1999). A Pediatric Case of HIV Protease Inhibitor-Induced Lipodystrophy. Pediatric Research. 45(4, Part 2 of 2). 159A–159A. 1 indexed citations

13.

Boyer, Jean, Jong Kim, Adam D. Cohen, et al.. (1999). HIV-1 DNA vaccines and chemokines. Vaccine. 17. S53–S64. 48 indexed citations

14.

MacGregor, Rob Roy, Jean Boyer, Kenneth E. Ugen, et al.. (1998). First Human Trial of a DNA-Based Vaccine for Treatment of Human Immunodeficiency Virus Type 1 Infection: Safety and Host Response. The Journal of Infectious Diseases. 178(1). 92–100. 503 indexed citations breakdown →

15.

Bagarazzi, Mark L., Jean Boyer, Kenneth E. Ugen, et al.. (1998). Safety and immunogenicity of HIV-1 DNA constructs in chimpanzees. Vaccine. 16(19). 1836–1841. 17 indexed citations

16.

Kim, Jong J., Liesl Nottingham, Darren M. Wilson, et al.. (1998). Engineering DNA vaccines via co-delivery of co-stimulatory molecule genes. Vaccine. 16(19). 1828–1835. 63 indexed citations

17.

Boyer, Jean, Kenneth E. Ugen, Michael A. Chattergoon, et al.. (1997). DNA Vaccination as Anti—Human Immunodeficiency Virus Immunotherapy in Infected Chimpanzees. The Journal of Infectious Diseases. 176(6). 1501–1509. 40 indexed citations

18.

Ugen, Kenneth E., Jean Boyer, Bin Wang, et al.. (1997). Nucleic acid immunization of chimpanzees as a prophylactic/immunotherapeutic vaccination model for HIV-1: prelude to a clinical trial. Vaccine. 15(8). 927–930. 20 indexed citations

19.

Kim, Jong J., Velpandi Ayyavoo, Mark L. Bagarazzi, et al.. (1997). Development of a multicomponent candidate vaccine for HIV-1. Vaccine. 15(8). 879–883. 32 indexed citations

20.

Bagarazzi, Mark L., et al.. (1996). Pulmonary Mycobacterium gordonae Infection in a Two-Year-Old Child: Case Report. Clinical Infectious Diseases. 22(6). 1124–1125. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact